Does the Clearant Process® address both current and emerging regulatory requirements for viral safety?
A. Yes. The Clearant Process® addresses many changing regulatory requirements worldwide including: proven effectiveness against a broad range of pathogens (including lipid enveloped and non-enveloped viruses); the demand for robust viral inactivation methods; and increasingly strict standards for viral safety and sterility assurance for human and animal derived products, biotech products, biologics used in manufacturing and biologics regulated as devices, drugs or tissues.
Related Questions
- Are there special regulatory requirements for research involving children as subjects who are also wards?
- Does the Clearant Process® address both current and emerging regulatory requirements for viral safety?
- How do these new offerings address evolving market requirements and emerging trends in our industry?
